Host-pathogen sympatry and differential transmissibility of Mycobacterium tuberculosis complex

Matthias I. Gröschel, Francy J. Pérez-Llanos, Roland Diel, Roger Vargas, Vincent Escuyer, Kimberlee A. Musser, Lisa Trieu, Jeanne Sullivan Meissner, Jillian Knorr, Don Klinkenberg, P. M. Kouw, Susanne Homolka, Wojciech Samek, Barun Mathema, Dick van Soolingen, Stefan Niemann, Shama D. Ahuja, Maha FarhatmedRxiv 2022 · DOI

TL;DR

Researchers have uncovered the first controlled evidence that Mycobacterium tuberculosis (Mtbc) lineages are biologically co-adapted to specific human populations. By analyzing large-scale contact tracing and genomic data, the study reveals that "specialist" TB strains are significantly less effective at infecting hosts from different ancestral backgrounds, suggesting that long-term evolution has "tuned" these pathogens to specific human niches.

What Problem Does This Paper Address?

For decades, scientists have noticed that different lineages of the Mycobacterium tuberculosis complex (Mtbc) aren't spread evenly across the globe. Some lineages are "generalists" (like the modern L2 and L4 strains) found everywhere, while others are "specialists" restricted to specific geographic regions and ethnic groups.

The big question has been: Is this distribution just a result of social mixing and migration patterns (sociology), or is there a deeper biological reason (evolution)? Proving the latter is notoriously difficult because you have to control for "founder effects" and complex social networks. This paper seeks to determine if these specialist strains are truly adapted to their local human populations—a concept known as sympatry—and whether they struggle to infect "allopatric" hosts (those from different geographic origins).

Methods

The study employed a powerful "one-two punch" of computational epidemiology and experimental biology:

  1. Epidemiological Modeling: The authors harmonized TB surveillance data from three major cosmopolitan cities: New York City, Amsterdam, and Hamburg. They combined detailed public health contact tracing data with Whole Genome Sequencing (WGS) of the pathogen.
  2. Statistical Rigor: They used Generalized Estimating Equations (GEE) and Quasi-Poisson models to calculate the odds of infection while controlling for a massive array of confounders, including age, sex, smear positivity (infectiousness), and social risk factors like homelessness or drug use.
  3. Transmission Inference: They utilized a Bayesian tool called Phybreak to reconstruct transmission trees, allowing them to estimate the probability of one specific person infecting another based on genomic distance and timing.
  4. In Vitro Validation: To move beyond correlation, they performed macrophage infection assays. They took human blood monocyte-derived macrophages from donors of European and African ancestry and infected them with different Mtbc lineages to measure uptake (phagocytosis) and intracellular growth.

Datasets

The study leveraged a massive multi-site cohort:

  • Initial Cohort: 5,256 TB cases and 28,889 linked contacts.
  • Final Analysis Cohort: 2,279 pulmonary TB index cases linked to 12,749 close contacts.
  • Genomic Data: WGS for over 99% of culture-positive cases, identifying nearly 300,000 single nucleotide substitutions (SNSs).
  • Validation Data: A global sample of 25,243 Mtbc strains with publicly available WGS to validate geographic origin definitions.

Key Insights and Ideas

  • The "Generalist" Advantage: Modern L2 and L4 lineages are intrinsically more transmissible across diverse populations. Specialist lineages (L1, L3, L5, L6) have significantly longer "terminal branch lengths" in their phylogeny, indicating they spend more time in individual hosts and less time jumping between them.
  • The Sympatry Signal: The most striking finding is that when a specialist strain encounters an "allopatric" host (a mismatch between the pathogen's ancestral home and the host's ancestry), the odds of infection drop by 32%. This is the "smoking gun" for biological co-adaptation.
  • Biological Barriers: The "failure" of specialist strains in new populations isn't just social; it's cellular. In the lab, specialist L6 strains showed a 10-fold decrease in their ability to be taken up by and grow within European macrophages compared to generalist L4 strains.
  • Evolutionary Trade-offs: The data suggests that as Mtbc specialized to thrive in specific human niches, it may have lost the "broad-spectrum" infectivity required to dominate in a globalized, cosmopolitan world.

Key Results

  • Lower Transmissibility: Specialist lineages had a lower adjusted incidence rate ratio (IRRadj 0.86) for infection among contacts compared to generalists.
  • Infection Odds: Allopatric host-pathogen exposures resulted in a 32% decrease in the odds of infection (ORadj 0.68) compared to sympatric exposures.
  • Macrophage Performance: In European macrophages, L6 (specialist) uptake was only 2.9%, compared to 33.9% for L4 (generalist). Conversely, in African donor macrophages, L6 actually grew better than L4 at certain time points, reinforcing the idea of local adaptation.

Limitations and Future Work

The authors acknowledge several hurdles:

  • Proxy Data: They used "country of birth" as a proxy for host ancestry, which can be imprecise in a globalized world.
  • Recall Bias: Contact tracing relies on patient interviews, which are subject to memory errors.
  • Missing Variables: Data on certain risk factors (like contact HIV or diabetes status) was not consistently available across all three cities.
  • The "How": While the study proves co-adaptation exists, the specific molecular and immunological mechanisms—the actual genes in the human and the bacteria that interact—remain to be identified.

Future work will likely focus on identifying these genetic "lock and key" mechanisms, which could be revolutionary for designing population-specific vaccines or targeted TB control strategies.

Summary updated

Abstract

SUMMARY The obligate human pathogen Mycobacterium tuberculosis complex ( Mtbc ) separates genetically into nine lineages several of which demonstrate sympatry with their human host i.e. have distinct and restricted patterns of geographical distribution globally. 1–3 Geographically restricted Mtbc lineages have been hypothesized to be adapted to infect and/or transmit among sympatric human hosts, i . e . to be niche specialists, but this is yet to be confirmed while controlling for exposure, social networks and risk of disease after exposure. 1,4 Here we show that strains of geographically restricted ( Mtbc lineages L1,L2 restricted , L3,L4 restricted , L5,L6 are intrinsically less transmissible than widespread Mtbc lineages (L2 widespread , L4 widespread ) across Western European and North American cosmopolitan populations. Comparing transmissibility between sympatric and allopatric contact-pathogen pairs, we find the first controlled evidence for a biological impact of sympatry between Mtbc strains and their human hosts; allopatric host-pathogen exposures has a 38% decrease in the odds of infection among contacts compared with sympatric exposures. We measure 10- fold lower phagocytosis and growth rates of L6 geographically restricted strains compared to L4 widespread in in vitro allopatric macrophage infections. Long-term co-existence of Mtbc strains and humans has resulted in differential transmissibility between allopatric and sympatric hosts for strains of geographically restricted lineages. Understanding the specific genetic and immunological underpinnings of sympatry in TB may inform rational vaccine design and TB control.
BibTeX
@misc{groschel2022host,
  author = {Matthias I. Gröschel and Francy J. Pérez-Llanos and Roland Diel and Roger Vargas and Vincent Escuyer and Kimberlee A. Musser and Lisa Trieu and Jeanne Sullivan Meissner and Jillian Knorr and Don Klinkenberg and P. M. Kouw and Susanne Homolka and Wojciech Samek and Barun Mathema and Dick van Soolingen and Stefan Niemann and Shama D. Ahuja and Maha Farhat},
  title = {{Host-pathogen sympatry and differential transmissibility of <i>Mycobacterium tuberculosis complex</i>}},
  year = {2022},
  doi = {10.1101/2022.08.04.22278337},
  howpublished = {medRxiv},
}

Loading related content...

Figure